ProductLife Group (PLG) and Juuka Advisory have teamed up to form a new consulting offering, ProductLife Consulting.
ProductLife Group (PLG), a regulatory compliance and outsourcing services specialist, and Juuka Advisory, an operations consulting company, have teamed up to form a new consulting offering, ProductLife Consulting. The partnership was announced in a Sep. 20, 2021 press release.
Both PLG and Juuka will draw from their expertise and operational experience to provide an end-to-end services portfolio for the pharma, biotech, medtech, and cosmetics markets through the new venture. ProductLife Consulting will be headed by Jean-Luc Taborin, who is Jukka’s CEO.
“I’m proud to join PLG, a leader in regulatory compliance outsourcing services,” said Taborin, in the press release. “With their knowledge of drug development, we’ll be able to tackle any perspective of the development of pharma, biotech, medtech, or cosmetics companies end-to-end.”
“This is a key milestone in PLG’s roadmap to strengthen its consulting offering with senior principals such as Jean-Luc and his team,” added Xavier Duburcq, CEO of ProductLife Group, in the press release. “PLG’s service offering and global footprint can now be proposed as a follow-up to any strategic recommendation that ProductLife Consulting makes to groups that want to accelerate and perform in their markets.”
Source: PLG
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.